Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-15T15:20:34.609Z Has data issue: false hasContentIssue false
  • English
  • Français

ADHERENCE IN PREGNANCY: A SYSTEMATIC REVIEW OF THE LITERATURE

Published online by Cambridge University Press:  28 September 2012

MARY OLADEJO  and
SUSAN BEWLEY
MARY OLADEJO*
Affiliation:
Kings College London c/o Women's Health Academic Centre, St Thomas’ Hospital London SE1 7EH
SUSAN BEWLEY
Affiliation:
Kings College London c/o Women's Health Academic Centre, St Thomas’ Hospital London SE1 7EH
*
*Mary Oladejo, Kings College London c/o Women's Health Academic Centre, 10th floor North Wing, St Thomas’ Hospital Westminster Bridge Rd, London SE1 7EH, United Kingdom. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

“Clinical decisions and research programs ultimately depend on the reliable and valid measurement of adherence. Yet, 50 years of research in this field have not provided the data necessary to answer critical measurement questions.”.

Type
Review Article
Information
Fetal and Maternal Medicine Review , Volume 23 , Issue 3-4 , November 2012 , pp. 201 - 229
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1DiMatteo, M. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200–209.Google Scholar
2Horne, R, Weinman, J, Barber, N, Elliott, RA, Morgan, M. Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. London, NCCSDO, 2005.Google Scholar
3NICE. Medicines concordance: Scope, 2007. Available at http://www.nice.org.uk/nicemedia/live/11638/37725/37725.pdf. Accessed 03/13, 2012.Google Scholar
4Bell, JS, Airaksinen, MS, Lyles, A, Chen, TF, Aslani, P. Concordance is not synonymous with compliance or adherence. Brit J Clin Pharmaco 2007; 64, 710–711.Google Scholar
5Neame, R, Hammond, A, Deighton, C. Need for information and for involvement in decision making among patients with rheumatoid arthritis: A questionnaire survey. Arthrit Care Res 2005; 53: 249–55.CrossRefGoogle ScholarPubMed
6Osterberg, L, Blaschke, T. Adherence to medication. New Engl J Med 2005; 353: 487–97.CrossRefGoogle ScholarPubMed
7Aronson, JK. Time to abandon the term ‘patient concordance’. Brit J Clin Pharm 2007; 64, 711–13.Google Scholar
8Agid, O, Foussias, G, Remington, G. Long-acting injectable antipsychotics in the treatment of schizophrenia: Their role in relapse prevention. Expert Opin Pharm 2010; 11: 2301–317.Google Scholar
9Samman, Y, Krayem, A, Haidar, M, Mimesh, S, Osoba, A, Al-Mowaallad, A, et al.Treatment outcome of tuberculosis among Saudi nationals: Role of drug resistance and compliance. Clin Microbiol Infec 2003; 9: 289–94.Google Scholar
10Sethi, AK, Celentano, DD, Gange, SJ, Moore, RD, Gallant, JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003; 37: 1112–118.Google Scholar
11Wahl, LM, Nowak, MA. Adherence and drug resistance: Predictions for therapy outcome. Proc Biol Sci 2000; 267: 835–43.CrossRefGoogle ScholarPubMed
12Aronson, JK. Compliance, concordance, adherence. Brit J Clin Pharm 2007 63: 383–84.CrossRefGoogle ScholarPubMed
13Mulcahy, P. Bitter pill of wasted prescriptions. The Times, 2007; February 28, 18.Google Scholar
14NHS Institute for Innovation and Improvement. NHS innovation challenge prizes: Medicines - reducing waste, increasing benefits, 2012. Available at http://www.biginnovationsapply.institute.nhs.uk/challange/medicines-%E2%80%93-reducing-waste-increasing-benefits-0. Accessed 03/04, 2012.Google Scholar
15Abdulameer, SA, Sahib, MN, Aziz, NA, Hassan, Y, Alrazzaq, HA, Ismail, O. Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: A pilot study. Patient Prefer Adherence 2012 6: 101–108.CrossRefGoogle ScholarPubMed
16Ang, DC, Marinescu, L, Kuriyan, M. Physician compliance with platelet usage criteria. Arch Pathol Lab Med, 2008; 132: 1321–324.Google Scholar
17Grol, R, Grimshaw, J. From best evidence to best practice: Effective implementation of change in patients’ care. Lancet 2003; 362: 1225–230.CrossRefGoogle ScholarPubMed
18Bodenheimer, T. The movement for improved quality in health care. New Engl J Med 1999 340: 488–92.Google Scholar
19Friedman, RJ, Gallus, AS, Cushner, FD, FitzGerald, G, Anderson, FA. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin 2008; 24: 87–97.Google Scholar
20McGinty, J, Anderson, G. Predictors of physician compliance with American heart association guidelines for acute myocardial infarction. Crit Care Nurs Q 2008; 31: 161–72.Google Scholar
21Hawkins, TLA, Lange, IR, Gibson, PS. Compliance with a perinatal prophylaxis policy for prevention of venous thromboembolism after caesarean section. J Obstet Gynaecol Can, 2008; 30: 1110–117.CrossRefGoogle Scholar
22WHO. Adherence to long-term therapies. Evidence for action, 2003. Available at http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed on 29/03, 2012.Google Scholar
23Restrepo, RD, Alvarez, MT, Wittnebel, LD, Sorenson, H, Wettstein, R, Vines, DL, et al.Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis, 2008; 3: 371–84.Google Scholar
24Salt, E, Frazier, SK. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A narrative review of the literature. Orthop Nurs 2010; 29: 260–75.Google Scholar
25Valenstein, M, Ganoczy, D, McCarthy, JF, Myra, KH, Lee, TA, Blow, FC. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. J Clin Psychiatry 2006; 67: 1542–550.Google Scholar
26Zygmunt, A, Olfson, M, Boyer, CA, Mechanic, D. Interventions to improve medication adherence in schizophrenia. Am J Psych; 2002; 159; 1653–664.Google Scholar
27Peyrot, M, Rubin, RR, Kruger, DF, Travis, LB. Correlates of insulin injection omission. Diabetes Care 2010; 33: 240–45.CrossRefGoogle ScholarPubMed
28Sullivan, PS, Campsmith, ML, Nakamura, GV, Begley, EB, Schulden, J, Nakashima, AK. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS One, 2007; 2: e552.Google Scholar
29Pablos-Méndez, A, Knirsch, CA, Barr, RG, Lerner, BH, Frieden, TR. Nonadherence in tuberculosis treatment: Predictors and consequences in New York City. Am J Med 1997; 102: 164–70.Google Scholar
30Costello, K, Kennedy, P, Scanzillo, J. Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med 2008; 10: 225.Google ScholarPubMed
31Heffelfinger, JD, Voetsch, AC, Nakamura, GV, Sullivan, PS, McNaghten, AD, Huang, L. Nonadherence to primary prophylaxis against pneumocystis jirovecii pneumonia. PLoS One 2009; 4: e5002.Google Scholar
32RCOG. England and Wales - Office for National Statistics: Births and deaths in England and Wales, 2011. Available at http://www.rcog.org.uk/our-profession/research-services/statistics. Accessed on 03/04, 2012.Google Scholar
33Tooher, R, Gates, S, Dowswell, T, Davis, L. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period Cochrane Database Syst Rev 2010; 12, CD001689.Google Scholar
34Kahn, SR. The post-thrombotic syndrome: The forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis 2006; 21: 41–48.Google Scholar
35Haenen, JH, Janssen, MCH, van Langen, H, van Asten, WNJC, Wollersheim, H, van ‘t Hof Martin, A, et al.The postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmography. J Vasc Surg 1999 29: 1071–1076.Google Scholar
36Pengo, V, Lensing, AWA, Prins, MH, Marchiori, A, Davidson, BL, Tiozzo, F, et al.Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257–264.Google Scholar
37Fedullo, PF, Auger, WR, Kerr, KM, Rubin, LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465–472.CrossRefGoogle ScholarPubMed
38James, AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med 2007; 120: Supplement 2, S26–34.Google Scholar
39Bremme, KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153–68.Google Scholar
40Centre for Maternal and Child Enquiries (CMACE). Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011; 118: Suppl 1, 1–203.Google Scholar
41James, AH, Tapson, VF, Goldhaber, SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005; 193: 216–19.Google Scholar
42Larsen, TB, Sørensen, HT, Gislum, M, Johnsen, SP. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: A population-based nested case-control study. Thromb Res 2007; 120: 505–509.Google Scholar
43Lee, KW, Lip, GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: A systematic review. Arch Intern Med 2003; 163: 2368–392.Google Scholar
44RCOG. Reducing the risk of thrombosis and embolism during pregnancy and puerperium No. Green-Top Guideline No. 37a. London: RCOG, 2009.Google Scholar
45Stefano, VD, Martinelli, I, Rossi, E, Battaglioli, T, Za, T, Mannuccio Mannucci, P, et al.The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol, 2006; 135: 386–91.Google Scholar
46Ernest, J, Marshburn, P, Kutteh, WH. Obstetric antiphospholipid syndrome: An update on pathophysiology and management. Semin Reprod Med. 2011; 29: 522–39.Google Scholar
47Brown, HL, Bobrowski, RA. Anticoagulation. Clin Obstet Gynecol 1998; 41: 545–54.Google Scholar
48Nelson-Piercy, C. 6 hazards of heparin: Allergy, heparin-induced thrombocytopenia and osteoporosis. Baillière's Clin Obstet Gynaecol 1997; 11: 489–509.CrossRefGoogle Scholar
49Hall, JG, Pauli, RM, & Wilson, K. M.Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med, 1980; 68: 122–40.Google Scholar
50Ginsberg, JS, Chan, WS, Bates, SM, Kaatz, S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003; 163: 694–98.Google Scholar
51Hung, L, Rahimtoola, SH. Prosthetic heart valves and pregnancy. Circulation 2003; 107: 1240–246.CrossRefGoogle ScholarPubMed
52Wilke, T, Müller, S. Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: A systematic review. Expert Rev Pharmacoecon Outcomes Rese 2010; 10: 691–700.Google Scholar
53Wilke, T, Moock, J, Müller, S, Pfannkuche, M, Kurth, A. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery. Clin Orthop Relat Res 2010; 468: 2437–453.CrossRefGoogle ScholarPubMed
54Confidential Enquiries into Maternal Deaths. Confidential enquiry into maternal and child health. Why mothers die 2000–2002: The sixth report of the confidential enquiry into maternal death in the United Kingdom. London: RCOG Press, 2004.Google Scholar
55Bardeguez, AD, Lindsey, JC, Shannon, M. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr 2008; 48: 408–417.Google Scholar
56Cohn, SE, Umbleja, T, Mrus, J, Bardeguez, AD, Andersen, JW, Chesney, MA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care STDs 2008; 22: 29–40.Google Scholar
57Demas, PA, Thea, DM, Weedon, J. Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: The impact of social network factors, side effects, and perceived treatment efficacy. Women Health 2005; 42: 99–15.Google Scholar
58Habib, F, Alabdin, EHZ, Alenazy, M. Compliance to iron supplementation during pregnancy. J Obstet Gynaecol 2009; 29: 487–92.Google Scholar
59Jasti, S, Siega-Riz, AM, Cogswell, ME, Hartzema, AG, Bentley, ME. Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr 2005; 135: 1093–101.Google Scholar
60Knudsen, VK, Orozova-Bekkevold, I, Rasmussen, LB, Mikkelsen, TB, Michaelsen, KF, Olsen, SF. Low compliance with recommendations on folic acid use in relation to pregnancy: Is there a need for fortification? Public Health Nutr 2004; 7: 843–50.Google Scholar
61Kuonza, LR, Tshuma, CD, Shambira, GN. Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: A cross-sectional analytic study. BMC Public Health, 2010 10: 218.Google Scholar
62Laine, C, Newschaffer, CJ, Zhang, D, Cosler, L, Hauck, WW, Turner, BJ. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis.Obstet Gynecol 2000; 95: 167–173.Google Scholar
63Nielsen, MJ, Norgaard, M, Holland-Fisher, P, Christensen, LA. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease. Aliment Pharmacol Ther 2010; 32: 49–58.Google Scholar
64Seck, BC, Jackson, RT. Determinants of compliance with iron supplementation among pregnant women in Senegal. Public Health Nutr 2008; 11: 596–605.Google Scholar
65Turner, B, Newschaffer, CJ, Zhang, D, Cosler, L, Hauck, WW. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care, 2000 38: 911–25.Google Scholar
66Vaz, MJR, Barros, SMO, Palacios, R. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS 2007; 18: 28–32.Google Scholar
67Wilson, TE, Ickovics, JR, Fernandez, I, Koenig, LJ, Walter, E. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. Am J Obstet Gynecol 2001; 184: 1235–240.Google Scholar
68Patel, JP, Auyeung, V, Patel, RK, Marsh, MS, Green, B, Arya, R, et al.Women's views and adherence to enoxaparin therapy during pregnancy and the puerperium: P-MO-368. J Thromb Haemostasis, 2011 9, Suppl s2, 172.Google Scholar
69Pike, GN, Hobson, M, Hay, E, Nash, M, Hay, C, Byrd, L. A pilot audit of thromboprophylaxis compliance with low molecular weight heparin in pregnancy: P-TU-390. J Thromb Haemost, 2011 9, Suppl s2, 431.Google Scholar
70Rueda, S, Park-Wyllie Laura, Y, Bayoumi, A, Tynan, A, Antoniou, T, Rourke, S, et al.Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS Cochrane Database Syst Rev, 2006 3, CD001442.Google Scholar
71DeNavas-Walt, C, Proctor, BD, Smith, JC, US Census Bureau. Current population reports, P60–238, income, poverty, and health insurance coverage in the United States: 2009. US Government Printing Office, Washington DC: US Census Bureau, 2010.Google Scholar
72McLintock, C, McCowan, L, North, R. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009; 116: 1585–1592.Google Scholar